Group items tagged

What are the most common infectious diseases in September? With the low temperatures this week, consultations for respiratory diseases such as colds, flu, bronchitis, pharyngitis, and pneumonia intensified. How to get through this unusual beginning of September in a healthy way.

With that innocent act, Viccars unleashed upon his community the most feared disease of the age. The package had come from London, where bubonic plague had been raging for months, and the cloth harbored fleas that carried the disease…By the end of September, five more people in the neighborhood had died, and in the first there days of October there were four more deaths. At the end of the month the toll had reached 23. The plague had come to the remote village of Eyam.

Hypovitaminosis D among rheumatology outpatients in clinical practice.\nMouyis M, Ostor AJ, Crisp AJ, Ginawi A, Halsall DJ, Shenker N, Poole KE.\nRheumatology (Oxford). 2008 Sep;47(9):1348-51. Epub 2008 May 22.\nPMID: 18499714 \ndoi:10.1093/rheumatology/ken203

Low vitamin d levels predict stroke in patients referred to coronary angiography.\nPilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, März W.\nStroke. 2008 Sep;39(9):2611-3. Epub 2008 Jul 17.\nPMID: 18635847 \ndoi: 10.1161/STROKEAHA.107.513655

Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study. Gebauer SK, West SG, Kay CD, Alaupovic P, Bagshaw D, Kris-Etherton PM. Am J Clin Nutr. 2008 Sep;88(3):651-9. PMID: 18779280

itamin D and autoimmunity: new aetiological and therapeutic considerations. Arnson Y, Amital H, Shoenfeld Y. Ann Rheum Dis. 2007 Sep;66(9):1137-42. Epub 2007 Jun 8. Review. PMID: 17557889 doi:10.1136/ard.2007.069831

Safety of vitamin D3 in adults with multiple sclerosis. Kimball SM, Ursell MR, O'Connor P, Vieth R. Am J Clin Nutr. 2007 Sep;86(3):645-51. PMID: 17823429 Conclusions: Patients' serum 25(OH)D concentrations reached twice the top of the physiologic range without eliciting hypercalcemia or hypercalciuria. The data support the feasibility of pharmacologic doses of vitamin D3 for clinical research, and they provide objective evidence that vitamin D intake beyond the current upper limit is safe by a large margin.